{
    "symbol": "IBB",
    "slug": "ibb",
    "display_name": "IBB",
    "category": "stocks",
    "region": "US",
    "description": null,
    "url": "https://finscans.com/asset/ibb",
    "lang": "en",
    "as_of": "2026-05-31T23:25:18+00:00",
    "stats_30d": {
        "total_signals": 1,
        "bullish": 1,
        "bearish": 0,
        "neutral": 0,
        "explicit": 0,
        "inferred": 1,
        "avg_impact": 7,
        "avg_confidence": 78,
        "last_signal_at": "2026-05-29 11:53:08",
        "article_count": 1
    },
    "top_catalysts": [
        {
            "text": "Sector-wide re-rating as more molecular glue deals are announced, boosting investor appetite for biotech stocks.",
            "count": 1
        },
        {
            "text": "Strong fundraising and partnership activity in the targeted protein degradation space indicates robust growth ahead.",
            "count": 1
        }
    ],
    "top_risk_factors": [
        {
            "text": "Macroeconomic headwinds or a shift away from risk-on sentiment could hurt biotech ETFs regardless of fundamental progress.",
            "count": 1
        },
        {
            "text": "If molecular glue hype fades due to clinical setbacks, the entire biotech sector may face a pullback.",
            "count": 1
        }
    ],
    "recent_signals": [
        {
            "signal_at": "2026-05-29 11:53:08",
            "sentiment": "Bullish",
            "impact_score": 7,
            "confidence_score": 78,
            "mention_type": "inferred",
            "timeframe": "short-term",
            "region": "US",
            "reasoning": "The iShares Biotechnology ETF (IBB) holds a basket of biotech firms, including those benefiting from molecular glue enthusiasm. Positive momentum in targeted protein degradation deals lifts the entire sector, and IBB is set to capture broad upside as capital flows into biotech innovation stories.",
            "article": {
                "title": "Molecular Glue Deals Surpass $1 Billion, Cementing Cancer Drug Breakthrough",
                "url": "https://finscans.com/news/molecular-glue-deals-surpass-1-billion-cementing-cancer"
            }
        }
    ]
}